PRIMARY PERITONEAL CAVITY CANCER
Clinical trials for PRIMARY PERITONEAL CAVITY CANCER explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PERITONEAL CAVITY CANCER trials appear
Sign up with your email to follow new studies for PRIMARY PERITONEAL CAVITY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug XMT-1660 enters first human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called XMT-1660 in people with advanced solid tumors, including triple-negative breast, ovarian, and endometrial cancers. The main goals are to find a safe dose and check for side effects. About 319 participants will receive the drug to see…
Matched conditions: PRIMARY PERITONEAL CAVITY CANCER
Phase: PHASE1 • Sponsor: Mersana Therapeutics • Aim: Disease control
Last updated May 26, 2026 06:25 UTC
-
New drug combo targets Hard-to-Treat ovarian cancer
Disease control Recruiting nowThis study tests whether two drugs, senaparib and temozolomide, can shrink tumors in people with a certain type of ovarian cancer that has an ARID1A gene change. About 18 adults with recurrent or persistent clear cell or endometrioid ovarian, fallopian tube, or primary peritoneal…
Matched conditions: PRIMARY PERITONEAL CAVITY CANCER
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 26, 2026 06:22 UTC